The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex.

scientific article

The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1074/JBC.M116.742981
P932PMC publication ID5207244
P698PubMed publication ID27754869

P50authorJessica HartmannQ63364071
Alexander SteinleQ39521645
P2093author name stringJoachim Koch
Sandra Weil
Tobias Zöller
Steffen Beyer
Eike Peters
Stefanie Memmer
P2860cites workNKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamilyQ22008826
Membrane integration and topology of the first transmembrane segment in normal and Southeast Asian ovalocytosis human erythrocyte anion exchanger 1.Q40386189
Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice.Q40850965
Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complexQ68128126
Surface expression of the T cell receptor complex requires charged residues within the alpha chain transmembrane regionQ69737071
Defective interactions between TCR chains and CD3 heterodimers prevent membrane expression of TCR-alpha beta in human T cellsQ71217184
Phosphorylation of T cell receptor zeta is regulated by a lipid dependent folding transitionQ73150636
Mapping the ends of transmembrane segments in a polytopic membrane protein. Scanning N-glycosylation mutagenesis of extracytosolic loops in the anion exchanger, band 3Q73500696
The short extracellular domain of the T cell receptor zeta chain is involved in assembly and signal transductionQ74178302
Scanning N-glycosylation mutagenesis of membrane proteinsQ79970313
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICAQ22010440
The structure of the zetazeta transmembrane dimer reveals features essential for its assembly with the T cell receptorQ24307955
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicityQ24310824
Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding siteQ24615889
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysisQ24647094
p46, a novel natural killer cell-specific surface molecule that mediates cell activationQ24647847
T cell activationQ24658051
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cellsQ24671834
Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3 epsilon gamma heterodimerQ27633054
Determination of the distance between the oligosaccharyltransferase active site and the endoplasmic reticulum membraneQ28267028
Functions of natural killer cellsQ29614300
NK cell recognitionQ29615107
Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6.Q30668576
Identification of a cellular ligand for the natural cytotoxicity receptor NKp44.Q33292077
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humansQ33292180
A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cellsQ33292224
Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cellsQ33292289
Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.Q33292532
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general populationQ33928216
Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attackQ34580297
Human natural killer cell development and biologyQ36346630
Surface NK receptors and their ligands on tumor cellsQ36490899
Surface expression of alternative forms of the TCR/CD3 complexQ37631971
Targeting natural killer cells and natural killer T cells in cancerQ37995950
Activating natural cytotoxicity receptors of natural killer cells in cancer and infectionQ38082002
BAG-6, a jack of all trades in health and diseaseQ38168708
The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand bindingQ38323488
Transmembrane folding of the human erythrocyte anion exchanger (AE1, Band 3) determined by scanning and insertional N-glycosylation mutagenesisQ38326334
Requirements for cell surface expression of the human TCR/CD3 complex in non-T cellsQ38335904
Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligandsQ39055067
P4510describes a project that usesImageJQ1659584
P433issue49
P407language of work or nameEnglishQ1860
P921main subjectligand bindingQ61659151
P1104number of pages12
P304page(s)25427-25438
P577publication date2016-10-17
P1433published inJournal of Biological ChemistryQ867727
P1476titleThe Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex
P478volume291